Universal Beteiligungs und Servicegesellschaft mbH Makes New $115.16 Million Investment in Elevance Health, Inc. (NYSE:ELV)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Elevance Health, Inc. (NYSE:ELV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 312,163 shares of the company's stock, valued at approximately $115,157,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.14% of Elevance Health as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Tobam raised its stake in Elevance Health by 6.6% during the 4th quarter. Tobam now owns 434 shares of the company's stock worth $160,000 after acquiring an additional 27 shares in the last quarter. Jacobi Capital Management LLC increased its position in shares of Elevance Health by 3.2% during the fourth quarter. Jacobi Capital Management LLC now owns 882 shares of the company's stock worth $325,000 after purchasing an additional 27 shares in the last quarter. Austin Private Wealth LLC lifted its holdings in shares of Elevance Health by 1.5% in the 4th quarter. Austin Private Wealth LLC now owns 1,996 shares of the company's stock valued at $736,000 after purchasing an additional 29 shares during the last quarter. Quent Capital LLC boosted its position in shares of Elevance Health by 2.1% in the 4th quarter. Quent Capital LLC now owns 1,488 shares of the company's stock valued at $549,000 after purchasing an additional 30 shares during the period. Finally, Keystone Financial Services grew its stake in Elevance Health by 2.4% during the 4th quarter. Keystone Financial Services now owns 1,436 shares of the company's stock worth $530,000 after buying an additional 33 shares during the last quarter. Hedge funds and other institutional investors own 89.24% of the company's stock.

Insider Transactions at Elevance Health

In related news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of Elevance Health stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $396.30, for a total value of $1,388,635.20. Following the completion of the transaction, the executive vice president now directly owns 10,116 shares in the company, valued at approximately $4,008,970.80. The trade was a 25.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Ronald W. Penczek sold 443 shares of the business's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $415.13, for a total transaction of $183,902.59. Following the transaction, the chief accounting officer now directly owns 1,847 shares of the company's stock, valued at approximately $766,745.11. This represents a 19.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,535 shares of company stock valued at $3,521,612 in the last quarter. 0.29% of the stock is currently owned by company insiders.

Elevance Health Trading Up 0.5%

NYSE ELV traded up $2.04 during trading hours on Thursday, reaching $379.99. The company's stock had a trading volume of 1,629,200 shares, compared to its average volume of 1,531,612. The firm has a fifty day simple moving average of $416.19 and a 200-day simple moving average of $401.99. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50. Elevance Health, Inc. has a 52 week low of $357.45 and a 52 week high of $567.26. The stock has a market cap of $85.85 billion, a P/E ratio of 14.84, a P/E/G ratio of 1.18 and a beta of 0.66.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $11.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.60 by $1.37. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. The company had revenue of $48.77 billion during the quarter, compared to the consensus estimate of $46.26 billion. Equities analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Tuesday, June 10th will be paid a dividend of $1.71 per share. The ex-dividend date is Tuesday, June 10th. This represents a $6.84 annualized dividend and a yield of 1.80%. Elevance Health's dividend payout ratio is currently 26.69%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Elevance Health from a "hold" rating to a "buy" rating in a research note on Thursday, March 20th. Argus set a $465.00 target price on shares of Elevance Health in a research note on Friday, April 25th. Barclays increased their target price on shares of Elevance Health from $512.00 to $522.00 and gave the company an "overweight" rating in a report on Wednesday, April 23rd. Truist Financial raised their price target on Elevance Health from $480.00 to $510.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Finally, Robert W. Baird reissued a "neutral" rating and issued a $529.00 price target (down from $625.00) on shares of Elevance Health in a research note on Tuesday, April 15th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Elevance Health presently has a consensus rating of "Moderate Buy" and an average target price of $510.38.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.